Main content

National Funding

The MUR finances research mainly through the Research Programmes of Relevant National Interest (PRIN) and the Fund for Basic Research Investments (FIRB).

The DSF has obtained funding for the following projects:

PRIN 

2017

2015

  • " Pathogenesis mechanisms in the early stages of Alzheimer's disease: identification of pharmacological targets and biomarkers", Project leader Prof. Pier Luigi Canonico

2012

  • " Nanotechnologies to vary the progress of bone development in the vessel wall for the prevention and treatment of pathologies associated with arterial ectopic calcification " (project leader Prof. Michela Bosetti – DSF national coordinator)

2010-11

  • "SynAD - Synaptic alterations in Alzheimer's disease: from the generation of new in vitro models to the identification of new targets " (project leader Prof. Pier Luigi Canonico)
  • "Italian network for the development of multivalent nanosystems" - MULTINANOITA (project leader Prof. Grazia Lombardi)
  • " The immune response mediated by NK cells against haematological neoplasms: study of the effector and regulatory functions and of innovative therapeutic approaches" (Project leader Prof. Antonio Sica)
  • " Design, synthesis, and biological studies of innovative drugs towards important targets in cancer therapy " (Project leader Prof. Gian Cesare Tron)

FIRB

2011

  • " Inflammation and cancer: innovative approaches based on nanotechnology " (Project leader Prof. Antonio Sica)

Other national funding:

  • Istituto Zooprofilattico Sperimentale Piemonte Liguria Valle d'Aosta "Developing innovative methods for detecting emerging food allergens and evaluation of their impact on consumer health: an integrated approach" (project leader of local team Prof. Jean Daniel Coisson)
  • Istituto Zooprofilattico Sperimentale Piemonte Liguria Valle d'Aosta "Taking a step forwards the preparedness for preventing crises: Improving the molecular detection of emerging pathogens in food" (project leader Prof. Marco Arlorio)
  • Humanitas "The role of macrophages in primary biliary cirrhosis: novel targets for immune intervention" (project leader Prof. Chiara Porta)

Last modified 19 July 2022